● Recruiting

A Study of DB-1310 in Advanced/Metastatic Solid Tumors

Condition: Advanced Solid Tumor · Sponsor: DualityBio Inc.

PhasePhase 1/Phase 2

Planned participants1000

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

This is a dose-escalation and dose-expansion Phase 1/2a trial to evaluate the safety and tolerability of DB-1310 in subjects with advanced solid tumors.

This description comes directly from the study's public registry record.

Talk to the study team

Tiana Zhao · 1-626-433-3820 · tiana.zhao@dualitybiologics.com

Lingling Gu · lingling.gu@dualitybiologics.com

Always discuss trial participation with your own doctor first.

Locations (24)

University of California, Davis Comprehensive Cancer Center	Sacramento, California, United States	Recruiting
UCLA Hematology/Oncology - Santa Monica	Santa Monica, California, United States	Recruiting
Research Site 117	Coral Gables, Florida, United States	Withdrawn
D&H Cancer Research Center LLC	Margate, Florida, United States	Withdrawn
Sarah Cannon Research Institute at Florida Cancer Specialists	Orlando, Florida, United States	Recruiting
BRCR global	Plantation, Florida, United States	Recruiting
Florida Cancer Specialists	Sarasota, Florida, United States	Recruiting
BRCR Medical Center Inc.	Tamarac, Florida, United States	Recruiting
Research Site 111	Atlanta, Georgia, United States	Recruiting
Dana-Farber Cancer Institute	Boston, Massachusetts, United States	Recruiting
Henry Ford Health System	Detroit, Michigan, United States	Recruiting
Research site 119	Florham Park, New Jersey, United States	Active Not Recruiting

+ 12 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05785741